{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:34:57Z","timestamp":1770748497323,"version":"3.50.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Since the beginning of the severe acute respiratory syndrome coronavirus 2 pandemic, there has been a large increase in the consumption of antimicrobials, both as a form of treatment for viral pneumonia, which has been shown to be ineffective, and in the treatment of secondary infections that arise over the course of the severe presentation of coronavirus disease 2019 (COVID-19). This increase in consumption, often empirical, ends up causing an increase in the incidence of colonization and secondary infections by multi and pan-resistant germs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The presence of a hyperinflammatory condition induced by the primary infection, associated with the structural damage caused by viral pneumonia and by the greater colonization by bacteria, generally multiresistant, are important risk factors for the acquisition of secondary infections in COVID-19. Consequently, there is an increased prevalence of secondary infections, associated with a higher consumption of antimicrobials and a significant increase in the incidence of infections by multi and pan-resistant bacteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Antimicrobial stewardship and improvement in diagnostic techniques, improving the accuracy of bacterial infection diagnosis, may impact the antibiotic consumption and the incidence of infections by resistant pathogens.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000975","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T03:00:09Z","timestamp":1661482809000},"page":"463-469","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Bacterial infection in coronavirus disease 2019 patients: co-infection, super-infection and how it impacts on antimicrobial use"],"prefix":"10.1097","volume":"28","author":[{"given":"Wagner","family":"Nedel","sequence":"first","affiliation":[{"name":"Hospital de Clinicas de Porto Alegre"},{"name":"Hospital Nossa Senhora Concei\u00e7\u00e3o"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"da Silveira","sequence":"additional","affiliation":[{"name":"Hospital Nossa Senhora Concei\u00e7\u00e3o"},{"name":"Programa de Pos-Gradua\u00e7\u00e3o Ciencias Pneumol\u00f3gicas, UFRGS, Porto Alegre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristofer Farias","family":"da Silva","sequence":"additional","affiliation":[{"name":"Hospital de Clinicas de Porto Alegre"},{"name":"Programa de Pos-Gradua\u00e7\u00e3o Ciencias Pneumol\u00f3gicas, UFRGS, Porto Alegre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago","family":"Lisboa","sequence":"additional","affiliation":[{"name":"Hospital de Clinicas de Porto Alegre"},{"name":"Programa de Pos-Gradua\u00e7\u00e3o Ciencias Pneumol\u00f3gicas, UFRGS, Porto Alegre"},{"name":"Universidade LaSalle, Canoas"},{"name":"Instituto de Pesquisa HCOR, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","article-title":"Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study","volume":"2","author":"Russell","year":"2021","journal-title":"Lancet Microbe"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"e13429","DOI":"10.1111\/eci.13429","article-title":"Deciphering the COVID-19 cytokine storm: systematic review and meta-analysis","volume":"51","author":"Mulchandani","year":"2021","journal-title":"Eur J Clin Investig"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/SHK.0000000000001724","article-title":"Severe COVID-19: immunosuppression or hyperinflammation?","volume":"56","author":"Liu","year":"2021","journal-title":"Shock"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"e12560","DOI":"10.15252\/emmm.202012560","article-title":"SARS -CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID -19?","volume":"12","author":"Bengoechea","year":"2020","journal-title":"EMBO Mol Med"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1080\/22221751.2020.1812437","article-title":"Risks and features of secondary infections in severe and critical ill COVID-19 patients","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-020-00243-2","article-title":"COVID-19: immunopathogenesis and Immunotherapeutics","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"R7-20250729","first-page":"11","article-title":"The lower respiratory tract microbiome of critically ill patients with COVID-19","author":"Gaibani","year":"2021","journal-title":"Scientific Rep"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1007\/s00134-020-06292-z","article-title":"Pulmonary infections complicating ARDS","volume":"46","author":"Luyt","year":"2020","journal-title":"Intensive Care Med"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1164\/rccm.202101-0030OC","article-title":"Early bacterial identification among intubated patients with COVID-19 or influenza pneumonia: a European multicenter comparative clinical trial","volume":"204","author":"Rouz\u00e9","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.chest.2020.10.014","article-title":"Global impact of coronavirus disease 2019 infection requiring admission to the ICU: a systematic review and meta-analysis","volume":"159","author":"Tan","year":"2021","journal-title":"Chest"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13054-021-03460-5","article-title":"Ventilator-associated pneumonia in critically ill patients with COVID-19","volume":"25","author":"Maes","year":"2021","journal-title":"Critical Care"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00134-020-06323-9","article-title":"Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study","volume":"47","author":"Rouz\u00e9","year":"2021","journal-title":"Intensive Care Med"},{"key":"R14-20250729","first-page":"74","article-title":"Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients","volume":"28","author":"Fumagalli","year":"2022","journal-title":"Curr Opin Crit Care"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/antibiotics10050545","article-title":"Ventilator-associated pneumonia in patients with COVID-19: a systematic review and meta-analysis","volume":"10","author":"Ippolito","year":"2021","journal-title":"Antibiotics"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13613-021-00971-w","article-title":"Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study","volume":"11","author":"Massart","year":"2021","journal-title":"Ann Intensive Care"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00134-021-06346-w","article-title":"COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network","volume":"47","author":"Buetti","year":"2021","journal-title":"Intensive Care Med"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"e00995-20","DOI":"10.1128\/JCM.00875-20","article-title":"Bacteremia and blood culture utilization during covid-19 surge in New York City","volume":"58","author":"Sepulveda","year":"2020","journal-title":"J Clin Microbiol"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1017\/ice.2020.368","article-title":"Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge","volume":"42","author":"Nori","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajem.2021.09.040","article-title":"Bacterial infections and death among patients with Covid-19 versus non COVID-19 patients with pneumonia","volume":"51","author":"Scott","year":"2022","journal-title":"Am J Emerg Med"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","article-title":"Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study","volume":"2","author":"Russell","year":"2021","journal-title":"Lancet Microbe"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1164\/rccm.202101-0030OC","article-title":"Early bacterial identification among intubated patients with COVID-19 or influenza pneumonia: a European multicenter comparative clinical trial","volume":"204","author":"Rouz\u00e9","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cmi.2020.10.021","article-title":"Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors","volume":"27","author":"Ripa","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13756-020-00819-1","article-title":"Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis","volume":"9","author":"Li","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"R26-20250729","article-title":"Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study","volume":"12","author":"Massart","year":"2021","journal-title":"Ann Intensive Care"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.chest.2021.04.002","article-title":"Hospital-acquired infections in critically ill patients with COVID-19","volume":"160","author":"Grasselli","year":"2021","journal-title":"Chest"},{"key":"R29-20250729","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"106020","DOI":"10.1016\/j.ijantimicag.2020.106020","article-title":"Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: what molecular dynamics studies of virus-host interactions reveal","volume":"56","author":"Fantini","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"104228","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb Pathog"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbrc.2020.10.042","article-title":"The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2?","volume":"538","author":"Jans","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"(7)","key":"R33-20250729","article-title":"Antibiotics for the treatment of COVID-19","author":"Popp","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1017\/ice.2020.1227","article-title":"Impact of the pandemic on antimicrobial consumption patterns","volume":"42","author":"da Silva","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(21)00149-5","article-title":"Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"Abaleke","year":"2021","journal-title":"Lancet"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/jama.2020.22240","article-title":"Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial","volume":"324","author":"Self","year":"2020","journal-title":"JAMA"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s10096-021-04213-6","article-title":"Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit","volume":"40","author":"Maataoui","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10096-020-04063-8","article-title":"Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship","volume":"40","author":"Rothe","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R39-20250729","article-title":"Increase of antimicrobial consumption in a tertiary care hospital during the first phase of the COVID-19 pandemic","volume":"10","author":"Castro-Lopes","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/antibiotics10080935","article-title":"Antibiotics prescribing in intensive care settings during the COVID-19 era: a systematic review","volume":"10","author":"Abu-Rub","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9110816","article-title":"Impact of the COVID-19 pandemic on antimicrobial consumption and hospital-acquired candidemia and multidrug-resistant bloodstream infections","volume":"9","author":"Guisado-Gil","year":"2020","journal-title":"Antibiotics"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics10020132","article-title":"Evolution of antimicrobial consumption during the first wave of covid-19 pandemic","volume":"10","author":"Grau","year":"2021","journal-title":"Antibiotics"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms9010095","article-title":"Spread of carbapenem-resistant gram-negatives and candida auris during the COVID-19 pandemic in critically ill patients: one step back in antimicrobial stewardship?","volume":"9","author":"Magnasco","year":"2021","journal-title":"Microorganisms"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmi.2020.09.025","article-title":"Understanding the role of bacterial and fungal infection in COVID-19","volume":"27","author":"Rawson","year":"2021","journal-title":"Clin Microbiol Infect"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:12:14Z","timestamp":1753819934000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000975","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}